| CAS ID: | 152459-95-5 |
| Molecular Formula: | C29H31N7O |
| Molecular Weight: | 493.6 g/mol |
| Monoisotopic Mass: | 493.259 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | GLIVEC | IMATINIB MESYLATE | IMATINIB MESILATE | STI-571 | STI 571 | Gleevec | GLEEVEC | IMATINIB |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) | See All |
| InChI Key: | KTUFNOKKBVMGRW-UHFFFAOYSA-N | |
| Smiles: | CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1 | See All |
| Molfile: | Download |
| Target ID | Name | Interaction |
|---|---|---|
| T0024 | Platelet-derived growth factor receptor alpha | antagonist |
| T0028 | Platelet-derived growth factor receptor beta | antagonist |
| T0986 | Protein tyrosine kinase | inhibitor |
Reference Record 1
| PubMed ID | 27918111 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 2
| PubMed ID | 24140598 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Liver fibrosis |
| Process I | |||
| Process II | HSCs proliferation | ||
| Process III | |||
| Mechanism | |||
Reference Record 3
| PubMed ID | 24013728 | Target ID | |
| Uniprot ID | Name | ||
| Model | human,mice | Fibrosis Disease | Systemic sclerosis |
| Process I | |||
| Process II | fibroblasts accumulation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 4
| PubMed ID | 22691216 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Systemic sclerosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 5
| PubMed ID | 21716259 | Target ID | T0024 |
| Uniprot ID | Platelet-derived growth factor receptor alpha | Name | Platelet-derived growth factor receptor alpha |
| Model | mice | Fibrosis Disease | Renal fibrosis |
| Process I | attenue inflammation | ||
| Process II | myofibroblasts differentiation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 6
| PubMed ID | 21716259 | Target ID | T0028 |
| Uniprot ID | Platelet-derived growth factor receptor beta | Name | Platelet-derived growth factor receptor beta |
| Model | mice | Fibrosis Disease | Renal fibrosis |
| Process I | attenue inflammation | ||
| Process II | myofibroblasts differentiation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Reference Record 7
Reference Record 8
Reference Record 9
| PubMed ID | 19846571 | Target ID | |
| Uniprot ID | Name | ||
| Model | rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation,myofibroblasts acccumulation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting Abl mTORC1 | ||
Reference Record 10
| PubMed ID | 19151753 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro | Fibrosis Disease | Systemic sclerosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | Targeting c-Abl and Egr-1 | ||
Reference Record 11
Reference Record 12
| PubMed ID | 16835260 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Fibrosis |
| Process I | |||
| Process II | fibroblasts proliferation,fibroblasts migration | ||
| Process III | |||
| Mechanism | |||
Reference Record 13
| PubMed ID | 14504092 | Target ID | |
| Uniprot ID | Name | ||
| Model | human | Fibrosis Disease | Bone marrow fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 14
Reference Record 15
Reference Record 16